Monitored anesthesia care with dexmedetomidine in transfemoral percutaneous trans-catheter aortic valve implantation: two cases report
Korean Journal of Anesthesiology 2014³â 66±Ç 4È£ p.317 ~ p.321
¹ÚÈñ¼±(Park Hee-Sun) - University of Ulsan College of Medicine Asan Medical Center Department of Anesthesiology and Pain Medicine
±è°æ¹Ì(Kim Kyung-Mi) - University of Ulsan College of Medicine Asan Medical Center Department of Anesthesiology and Pain Medicine
(Jung Kyoung-Woon) - University of Ulsan College of Medicine Asan Medical Center Department of Anesthesiology and Pain Medicine
ÃÖÀÎö(Choi In-Cheol) - University of Ulsan College of Medicine Asan Medical Center Department of Anesthesiology and Pain Medicine
½ÉÁö¿¬(Sim Ji-Yeon) - University of Ulsan College of Medicine Asan Medical Center Department of Anesthesiology and Pain Medicine
Abstract
Percutaneous trans-catheter aortic valve implantation (TAVI) is recommended for inoperable patients with severe aortic stenosis at high risk for conventional aortic valve replacement. Originally, TAVI was mostly performed under general anesthesia. Here we describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine. Dexmedetomidine provides sedation, analgesia with minimal respiratory depression. Although MAC during transfemoral TAVI has limitations, such as unexpected patient movement and difficulty in intra-procedural use of transesophageal echocardiography, MAC with dexmedetomidine is feasible with close monitoring, fluoroscopic guidance and the participation of experienced anesthesiologists.
Å°¿öµå
Anesthesia, Dexmedetomidine, Heart valve prosthesis implantation, Hypnotics and Sedatives
KMID :
0356920140660040317
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
Here the two cases describe two cases of transfemoral TAVI performed under monitored anesthesia care (MAC) with dexmedetomidine.